Roche won another reprieve in its fight againstthousands of Accutane safety claims. The drugmaker persuaded a New Jersey appeals court to overturn an $18M jury…

Drug ingredients still flow to U.S. from banned China plant.

With the vast majority of drugs and drug ingredients being manufactured outside the U.S., the FDA has had to step up its international oversight and often ban…

Reports that a sales representative at Abbott Laboratories in India cited work performance demands in a suicide note have reverberated among colleagues.

Shortages of vaccines at clinics in China have predictably followed a move to eliminate middlemen from the sales chain.

The sun is finally shining on drug company payments to doctors in Europe, and payment information has begun to trickle out.

Valeant just got a new weapon in its battle with AstraZeneca for the opioid-induced constipation throne. But don't expect oral Relistor to power that…

China Resources has teamed up with Australian investment bank Macquarie to buy a majority of cancer and cardio medical care provider GenesisCare in a $1.3…

China’s Jilin Zixin Pharmaceutical Industrial has splashed out $42 million to buy a Rhode Island-based high-definition genome mapping company, Nabsys 2.0.